Core Viewpoint - Generac Holdings has experienced a decline in share price of approximately 5.4% since its last earnings report, underperforming the S&P 500 index [1][2]. Financial Performance - In Q4 2025, Generac reported adjusted earnings per share (EPS) of $1.61, missing the Zacks Consensus Estimate of $1.81, and down from $2.80 in the prior-year quarter [3]. - Net sales for the quarter were $1.09 billion, a decrease of 12% from $1.23 billion year-over-year, also falling short of the consensus estimate of $1.17 billion [3]. - Gross profit was $396.1 million, down from $501.4 million in the prior-year quarter, with gross margins of 36.3% compared to 40.6% previously [10]. Demand and Sales Trends - Weaker demand for home standby and portable generators was noted, which offset increases in sales to data center customers and higher shipments of residential energy technology products [4]. - Domestic revenues fell 17% year-over-year to $889 million, while international revenues increased by 12% to $209.2 million, aided by favorable foreign currency impacts [8]. Segment Performance - Residential product revenues decreased by 23% year-over-year to $572 million, while C&I (Commercial and Industrial) revenues rose by 10% to $400 million [9]. - The company anticipates a 10% increase in residential product sales for 2026, assuming a return to normal power outage activity [7]. Future Outlook - Management expects revenues to grow in the mid-teens percentage range for 2026, following a 2% decline in 2025, with C&I product sales projected to increase by around 30% [6]. - The net income margin is expected to be between 8% and 9%, with an adjusted EBITDA margin estimated at 18-19% [7]. Cash Flow and Share Repurchase - In Q4, Generac generated $189 million in net cash from operating activities, with free cash flow totaling $130 million [12]. - The company repurchased 1.1 million shares for $148 million in 2025 and has authorized an additional $500 million for share repurchases over the next 24 months [13]. Market Position and Estimates - Generac Holdings has a Zacks Rank of 3 (Hold), indicating an expectation of an in-line return in the coming months [16]. - The stock has a Growth Score of B and a Momentum Score of B, but a Value Score of D, placing it in the bottom 40% for value investors [15].

Core Viewpoint - Phinia (PHIN) has experienced significant selling pressure, resulting in a 16.6% decline over the past four weeks, but analysts anticipate improved earnings in the near future [1] Group 1: Technical Analysis - The Relative Strength Index (RSI) is utilized to determine if a stock is oversold, with a reading below 30 indicating oversold conditions [2] - PHIN's current RSI reading is 29.75, suggesting that the heavy selling may be nearing exhaustion, indicating a potential rebound [5] - The RSI helps identify price reversal points, allowing investors to seek entry opportunities when a stock is undervalued due to excessive selling [3] Group 2: Fundamental Indicators - Analysts have raised earnings estimates for PHIN by 0.2% over the last 30 days, indicating a consensus among sell-side analysts that could lead to price appreciation [7] - PHIN holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks, which supports the potential for a near-term turnaround [8]

分组1 - Evolus, Inc. reported quarterly earnings of $0.06 per share, matching the Zacks Consensus Estimate, and showing an increase from $0.01 per share a year ago [1] - The company posted revenues of $90.3 million for the quarter ended December 2025, exceeding the Zacks Consensus Estimate by 0.98% and up from $78.95 million year-over-year [2] - Evolus shares have declined approximately 35.5% since the beginning of the year, contrasting with the S&P 500's gain of 0.5% [3] 分组2 - The earnings outlook for Evolus is uncertain, with current consensus EPS estimates at -$0.11 for the coming quarter and -$0.04 for the current fiscal year, alongside revenues of $71.74 million and $330.94 million respectively [7] - The Zacks Industry Rank indicates that the Medical - Products sector is in the bottom 41% of over 250 Zacks industries, suggesting potential underperformance compared to higher-ranked industries [8] - The estimate revisions trend for Evolus was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6]

分组1 - Oportun Financial Corporation reported quarterly earnings of $0.27 per share, exceeding the Zacks Consensus Estimate of $0.26 per share, but down from $0.49 per share a year ago, resulting in an earnings surprise of +3.85% [1] - The company achieved revenues of $247.7 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 1.40%, although this is a decrease from year-ago revenues of $250.9 million [2] - Oportun Financial has outperformed the S&P 500 with a share price increase of about 4.2% since the beginning of the year, compared to the S&P 500's gain of 1.5% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is $0.27 on revenues of $238.11 million, and for the current fiscal year, it is $1.43 on revenues of $972.14 million [7] - The Zacks Industry Rank for Financial - Miscellaneous Services is in the top 35% of over 250 Zacks industries, indicating that the industry outlook can significantly impact stock performance [8]

Core Viewpoint - Koppers (KOP) reported quarterly earnings of $0.7 per share, exceeding the Zacks Consensus Estimate of $0.59 per share, but down from $0.77 per share a year ago [1] Financial Performance - The earnings surprise for the quarter was +17.98%, while the previous quarter saw a surprise of -3.2% with actual earnings of $1.21 per share against an expectation of $1.25 [2] - Koppers posted revenues of $432.7 million for the quarter, missing the Zacks Consensus Estimate by 2.66%, and down from $477 million year-over-year [3] Stock Performance - Koppers shares have increased approximately 27.5% since the beginning of the year, compared to a 1.5% gain in the S&P 500 [4] Future Outlook - The company's earnings outlook is crucial for investors, with current consensus EPS estimates at $1.03 for the coming quarter and $4.57 for the current fiscal year, with revenues expected to be $463.6 million and $1.93 billion respectively [5][8] - The Zacks Rank for Koppers is currently 3 (Hold), indicating expected performance in line with the market [7] Industry Context - The Chemical - Diversified industry, to which Koppers belongs, is currently ranked in the bottom 23% of over 250 Zacks industries, suggesting potential challenges ahead [9]

Core Viewpoint - Huron Consulting (HURN) has experienced a significant decline of 21.2% in its stock price over the past four weeks, but the formation of a hammer chart pattern suggests a potential trend reversal as buying interest may be emerging to counteract selling pressure [1][2]. Technical Analysis - The hammer chart pattern indicates a minor difference between opening and closing prices, with a long lower wick, suggesting that the stock may have found support during a downtrend [4]. - This pattern typically forms when bears have control, but a subsequent buying interest can signal a potential reversal in the trend [5]. Fundamental Analysis - There has been a positive trend in earnings estimate revisions for HURN, with a 0.4% increase in the consensus EPS estimate for the current year, indicating that analysts expect better earnings than previously predicted [7][8]. - HURN holds a Zacks Rank of 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks, which historically indicates strong performance potential [9][10].

Core Insights - Solventum (SOLV) is set to release its fourth-quarter 2025 results on February 26, with previous earnings exceeding estimates by 4.90% and a trailing four-quarter average earnings surprise of 10.42% [1][3] Financial Estimates - The Zacks Consensus Estimate for Solventum's revenues is $1.96 billion, while the consensus for earnings is $1.50 per share [2] Performance Overview - The company is expected to report strong underlying momentum in Q4 2025, following a third quarter characterized by improved commercial execution and cost initiatives, although tariffs may negatively impact results [3][9] - Management raised full-year guidance to the high end of its organic growth range of 2-3% and adjusted EPS outlook from $5.88-$6.03 to $5.98-$6.08 [3][9] Segment Performance - MedSurg, the largest segment, achieved 1.1% organic growth in Q3, with Advanced Wound Care growing by 2.7% [4] - Infection Prevention and Surgical Solutions remained flat, indicating a reversal of earlier order timing benefits, while Dental Solutions saw a notable 6.5% organic growth [5][6] - Health Information Systems (HIS) posted 5.6% organic growth, driven by revenue cycle management software and favorable consulting milestones [8] Strategic Developments - The sale of the Purification & Filtration business in September increased the company's cash position by $4 billion, which is being utilized for debt reduction and potential acquisitions [9] - The company acquired Acera Surgical to enhance its MedSurg portfolio with synthetic tissue matrices technology [9] Margin and Cost Management - Gross margin in Q3 was 55.8%, impacted by a 130-basis-point tariff effect, with expectations of further tariff pressures in Q4 [11] - The "Transform for the Future" initiative aims for $500 million in annual savings over four years, which, along with supply chain efficiencies, is expected to support margin resilience [11]

Core Viewpoint - Expand Energy (EXE) reported quarterly earnings of $2 per share, exceeding the Zacks Consensus Estimate of $1.89 per share, and showing significant growth from $0.55 per share a year ago, indicating strong performance in the oil and gas sector [1] Financial Performance - The company achieved revenues of $2.31 billion for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 2.56%, and up from $1.6 billion in the same quarter last year [2] - Over the last four quarters, Expand Energy has exceeded consensus EPS estimates three times and topped revenue estimates two times [2] Stock Performance - Expand Energy shares have declined approximately 5.7% since the beginning of the year, contrasting with the S&P 500's slight decline of 0.1% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $2.34 on revenues of $2.46 billion, and for the current fiscal year, it is $8.19 on revenues of $9.43 billion [7] - The trend of earnings estimate revisions for Expand Energy was mixed prior to the earnings release, which may influence future stock performance [6] Industry Context - The Alternative Energy - Other industry, to which Expand Energy belongs, is currently ranked in the bottom 36% of over 250 Zacks industries, suggesting potential challenges ahead [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact investor sentiment [5]

分组1 - Legacy Education Inc. reported quarterly earnings of $0.15 per share, exceeding the Zacks Consensus Estimate of $0.13 per share, and showing an increase from $0.10 per share a year ago, resulting in an earnings surprise of +15.39% [1] - The company achieved revenues of $19.19 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 3.48%, and up from $13.64 million year-over-year [2] - Legacy Education Inc. has outperformed the market with a 3% increase in share price since the beginning of the year, compared to the S&P 500's gain of 1.4% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is $0.17 on revenues of $19.5 million, and for the current fiscal year, it is $0.66 on revenues of $76.6 million [7] - The Zacks Industry Rank for Schools is in the top 27% of over 250 Zacks industries, indicating a favorable outlook for the industry [8] - Legacy Education Inc. holds a Zacks Rank 3 (Hold), suggesting that the stock is expected to perform in line with the market in the near future [6]

Core Insights - Watts Water (WTS) reported quarterly earnings of $2.62 per share, exceeding the Zacks Consensus Estimate of $2.36 per share, and up from $2.05 per share a year ago [1][2] - The company achieved a revenue of $625.1 million for the quarter, surpassing the Zacks Consensus Estimate by 2.26%, compared to $540.4 million in the same quarter last year [3] Earnings Performance - The earnings surprise for the quarter was +10.89%, following a previous surprise of +9.17% when actual earnings were $2.5 per share against an expectation of $2.29 per share [2] - Watts Water has consistently outperformed consensus EPS estimates over the last four quarters [2] Revenue Performance - The company has also exceeded consensus revenue estimates in each of the last four quarters [3] - The revenue growth reflects a significant increase from the previous year's figures, indicating strong operational performance [3] Stock Performance - Since the beginning of the year, Watts Water shares have increased by approximately 14.1%, significantly outperforming the S&P 500's gain of 1.4% [4] - The sustainability of this price movement will depend on management's commentary during the earnings call [4] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $2.64, with expected revenues of $615.59 million, and for the current fiscal year, the estimate is $11.37 on $2.61 billion in revenues [8] - The favorable trend in estimate revisions prior to the earnings release has resulted in a Zacks Rank 2 (Buy) for the stock, suggesting expected outperformance in the near future [7] Industry Context - Watts Water operates within the Zacks Manufacturing - General Industrial industry, which is currently ranked in the top 28% of over 250 Zacks industries [9] - The strong industry ranking indicates a favorable environment for the company's performance relative to its peers [9]